These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 2547464)

  • 1. Mechanistic studies on effervescent-induced permeability enhancement.
    Eichman JD; Robinson JR
    Pharm Res; 1998 Jun; 15(6):925-30. PubMed ID: 9647360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters.
    Kobal G; Hummel C; Nuernberg B; Brune K
    Agents Actions; 1990 Mar; 29(3-4):342-59. PubMed ID: 2339674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diflunisal in patients.
    Nuernberg B; Koehler G; Brune K
    Clin Pharmacokinet; 1991 Jan; 20(1):81-9. PubMed ID: 2029803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction between indomethacin and diflunisal.
    Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    Eur J Clin Pharmacol; 1989; 36(5):507-12. PubMed ID: 2753070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diflunisal disposition. Role of gastric absorption in the development of mucosal damage and anti-inflammatory potency in rodents.
    Nuernberg B; Szelenyi I; Schneider HT; Brune K
    Drug Metab Dispos; 1990; 18(6):937-42. PubMed ID: 1981540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
    Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
    Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the animal and clinical pharmacology of diflunisal.
    Davies RO
    Pharmacotherapy; 1983; 3(2 Pt 2):9S-22S. PubMed ID: 6344042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buffering the stomach content enhances the absorption of diflunisal in man.
    Nuernberg B; Brune K
    Biopharm Drug Dispos; 1989; 10(4):377-87. PubMed ID: 2547464
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.